Literature DB >> 16759240

Deterioration in quality-of-life of late (10-year) survivors of head and neck cancer.

H M Mehanna1, R P Morton.   

Abstract

OBJECTIVES: To determine 10-year quality-of-life (QOL) in head and neck cancer patients and to examine the potential predictors of late QOL.
DESIGN: Prospective 10-year (QOL) assessment in a cohort of head and neck cancer patients.
SETTING: Tertiary referral head and neck cancer centre in Auckland, New Zealand. PARTICIPANTS: Two hundred patients diagnosed and were treated for head and neck cancer. Exclusion criteria were blindness, learning difficulties or inability to understand or read English. MAIN OUTCOME MEASURES: Quality-of-life at 10 years measured by Auckland QOL questionnaire, and analysed for associations with the following co-variates: age, gender; co-morbidities (alcohol intake and smoking), type and stage of disease; treatment modality; and QOL measures.
RESULTS: At 10 years following diagnosis, overall QOL (life satisfaction), decreased significantly by an average of 11% (95% CI: -5, -17) compared with before treatment, and by 15% when compared with years 1 and 2. Pre-treatment QOL significantly predicted late QOL, whilst QOL 1 year after treatment did not. None of the socio-demographic, disease- or treatment-related factors predicted long-term QOL on univariate analysis, but this may be due to the small sample size.
CONCLUSIONS: This observed, late drop in the QOL of head and neck cancer patients requires further corroboration and investigation. Due to small sample sizes associated with long-term studies in head and neck cancer cohorts, studies of predictors of long-term QOL will only be likely to succeed if done as multi-centre studies. As there is some evidence to suggest that psychosocial interventions improve the QOL of head and neck cancer patients, it may be appropriate to consider screening for risk of a late deterioration in QOL in order to plan appropriate psycho-social intervention.

Entities:  

Mesh:

Year:  2006        PMID: 16759240     DOI: 10.1111/j.1749-4486.2006.01188.x

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  17 in total

Review 1.  Advances in quality of life research among head and neck cancer patients.

Authors:  Allen C Sherman; Stephanie Simonton
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

Review 2.  The humanistic burden of head and neck cancer: a systematic literature review.

Authors:  Erika Wissinger; Ingolf Griebsch; Juliane Lungershausen; Michael Byrnes; Karin Travers; Chris L Pashos
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

3.  The eating experience in long-term survivors of head and neck cancer: a mixed-methods study.

Authors:  Heidi Ganzer; Pamela Rothpletz-Puglia; Laura Byham-Gray; Barbara A Murphy; Riva Touger-Decker
Journal:  Support Care Cancer       Date:  2015-04-08       Impact factor: 3.603

4.  Predictors of pain among patients with head and neck cancer.

Authors:  Andrew G Shuman; Jeffrey E Terrell; Emily Light; Gregory T Wolf; Carol R Bradford; Douglas Chepeha; Yunyun Jiang; Scott McLean; Tamer A Ghanem; Sonia A Duffy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-12-01

Review 5.  Psychological functioning of caregivers for head and neck cancer patients.

Authors:  Margaret L Longacre; John A Ridge; Barbara A Burtness; Thomas J Galloway; Carolyn Y Fang
Journal:  Oral Oncol       Date:  2011-12-09       Impact factor: 5.337

6.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621

7.  Factors associated with loss to follow-up after radiation therapy for head and neck cancer.

Authors:  John M Hoyle; Tanya A Correya; Kelly Kenzik; Liton Francisco; Sharon A Spencer; Christopher D Willey; James A Bonner; James W Snider; Drexell Hunter Boggs; William R Carroll; Smita Bhatia; Andrew M McDonald
Journal:  Head Neck       Date:  2022-01-25       Impact factor: 3.147

8.  Coping strategies predict post-traumatic stress in patients with head and neck cancer.

Authors:  Amy E Richardson; Randall P Morton; Elizabeth Broadbent
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-07       Impact factor: 2.503

9.  Health-related quality of life differences between African Americans and non-Hispanic whites with head and neck cancer.

Authors:  Bryce B Reeve; Jianwen Cai; Hongtao Zhang; Jaeun Choi; Mark C Weissler; David Cella; Andrew F Olshan
Journal:  Head Neck       Date:  2012-08-21       Impact factor: 3.147

10.  Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer.

Authors:  Carmen M Klass; Mi Sun Choe; Selwyn J Hurwitz; Mourad Tighiouart; Xin Zhang; Zhuo Georgia Chen; Dong M Shin
Journal:  Head Neck       Date:  2009-10       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.